GSK raised its full-year guidance after reporting a second-quarter adjusted operating profit of £2.2 billion and an above-forecast net profit.
GSK raised its full-year guidance after reporting a second-quarter adjusted operating profit of £2.2 billion and an above-forecast net profit.